Nathalie Beauregard Nathalie Beauregard

Alliance de l’énergie de l’Est and Invenergy in its closing of $1.1 billion in financing for the Pohénégamook-Picard-Saint-Antonin-Wolastokuk 1 (PPAW 1) Wind Energy Centre

On June 3, 2025, Alliance de l’énergie de l’Est and Invenergy announced the closing of $1.1 billion in financing for the Pohénégamook-Picard-Saint-Antonin-Wolastokuk 1 (PPAW 1) Wind Energy Centre. PPAW 1 will be developed as an equal partnership between Invenergy and the Alliance de...

Lead Office: Montreal Date Announced: June 3, 2025 Value: $1.1 billion

KisoJi in its raising of $57-million Series B financing

On December 6, 2024, KisoJi announced it raised $57 million of Series B financing. This round was co-led by Investissement Québec and Lumira Ventures. The round also saw participation from Fonds de solidarité FTQ, adMare BioInnovations and Remiges Ventures. The company plans on utilizing the...

Lead Office: Montreal Date Announced: December 6, 2024 Value: $57 million

BDC Capital in connection with Cyclic Material’s $71-million Series B financing round

On September 25, 2024, Cyclic Materials announced it raising of $71 million of Series B financing. This all-equity, all-primary financing round was led by ArcTern Ventures and included BDC Capital’s Climate Tech Fund, Hitachi Ventures, Zero Infinity Partners, Climate Investment, Microsoft...

Lead Office: Montreal Date Announced: September 25, 2024 Value: $71 million

Inversago Pharma in its US$1.075 billion business combination with Novo Nordisk

On August 10, 2023, Inversago Pharma announced its business combination with Nova Nordisk for US$1.075 billion pursuant to the completion of certain development and commercial milestones. This acquisition will strengthen Nova Nordisk’s clinical development and research capability for obesity and...

Lead Office: Montreal Date Closed: -- Value: US$1.075 billion

BoostSecurity in its $12 million seed funding

On November 16, 2022, BoostSecurity announced it had secured $12 million in seed funding led by Sorenson Capital, with participation from Hoxton Ventures, Golden Ventures, Firebolt Ventures and Transform VC. This all-equity round will help in expanding BoostSecurity’s product,...

Lead Office: Montreal Date Closed: November 16, 2022 Value: $12 million

Inversago Pharma in its $95 million Series C financing

On October 17, 2022, Inversago Pharma announced it had completed its $95 million Series C financing round led by New Enterprise Associates with participation from Forbion’s Growth Opportunities Fund, Amgen Ventures, Forbion’s Ventures Fund IV, Fonds de solidarité FTQ, Genesys...

Lead Office: Montreal Date Closed: October 17, 2022 Value: $95 million

BDC Capital in connection with Userful’s $10 million post-seed financing round

On April 29, 2022, Userful, a Calgary-based company that specializes in video walls, digital signage, interactive displays and desktop virtualization, announced it had completed its $10 million post-seed financing round with participation from BDC Capital’s Industrial, Clean and Energy...

Lead Office: Montreal Date Closed: April 29, 2022 Value: $10 million

Milestone Pharmaceuticals Inc. in its $45 million public offering

On October 27, 2020, Milestone Pharmaceuticals Inc. completed its $45 million public offering. The offering was made through a syndicate of underwriters with Jefferies and Piper Sandler as joint book running managers for the offering and Oppenheimer & Co. as lead manager. Milestone...

Lead Office: Montreal Date Closed: October 27, 2020 Value: $45 million

Hivestack in its $10 million equity financing

On August 11, 2020, Hivestack secured $10 million in equity financing from Investissement Quebec. The funding will be used to support Hivestack’s global expansion and allow the company to expand its workforce in its Montreal headquarters and globally. The funding will also allow...

Lead Office: Montreal Date Closed: August 10, 2020 Value: $10 million

LQT Therapeutics Inc. in its $1.8 million seed round

On November 6, 2019, LQT Therapeutics Inc. (LQTT) closed the first tranche of its $1.8 million seed round led by Fonds de solidarité des travailleurs du Québec (F.T.Q.). The funding will be used to accelerate research of new therapies for Long QT Syndrome (LQTS) and other cardia...

Lead Office: Montreal Date Closed: November 6, 2019 Value: $1.8 million